Ubs Asset Management Americas Inc Haemonetics Corp Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 128,123 shares of HAE stock, worth $9.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128,123
Previous 131,766 2.76%
Holding current value
$9.67 Million
Previous $10.9 Million 5.54%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$72.45 - $91.58 $263,935 - $333,625
-3,643 Reduced 2.76%
128,123 $10.3 Million
Q2 2024

Aug 13, 2024
BUY
$81.24 - $97.37 $5.13 Million - $6.15 Million
63,189 Added 92.14%
131,766 $10.9 Million
Q1 2024

May 15, 2024
BUY
$71.24 - $85.35 $561,727 - $672,984
7,885 Added 12.99%
68,577 $5.85 Million
Q4 2023

Feb 14, 2024
SELL
$80.59 - $92.61 $107,345 - $123,356
-1,332 Reduced 2.15%
60,692 $5.19 Million
Q3 2023

Nov 13, 2023
SELL
$82.56 - $93.49 $400,581 - $453,613
-4,852 Reduced 7.26%
62,024 $5.56 Million
Q1 2023

May 15, 2023
BUY
$72.75 - $90.6 $668,645 - $832,704
9,191 Added 15.93%
66,876 $5.53 Million
Q4 2022

Feb 14, 2023
BUY
$73.85 - $86.14 $268,149 - $312,774
3,631 Added 6.72%
57,685 $4.54 Million
Q3 2022

Nov 14, 2022
SELL
$63.3 - $78.66 $453,861 - $563,992
-7,170 Reduced 11.71%
54,054 $4 Million
Q2 2022

Aug 12, 2022
SELL
$49.27 - $66.08 $27,197 - $36,476
-552 Reduced 0.89%
61,224 $3.99 Million
Q1 2022

May 16, 2022
BUY
$43.77 - $63.22 $17,989 - $25,983
411 Added 0.67%
61,776 $3.91 Million
Q4 2021

Feb 14, 2022
BUY
$49.55 - $74.59 $22,892 - $34,460
462 Added 0.76%
61,365 $3.25 Million
Q3 2021

Nov 15, 2021
SELL
$57.6 - $70.59 $19,238 - $23,577
-334 Reduced 0.55%
60,903 $4.3 Million
Q2 2021

Aug 16, 2021
SELL
$51.81 - $118.56 $1.12 Million - $2.57 Million
-21,640 Reduced 26.11%
61,237 $4.08 Million
Q1 2021

May 14, 2021
SELL
$111.01 - $139.48 $206,478 - $259,432
-1,860 Reduced 2.2%
82,877 $9.2 Million
Q4 2020

Mar 01, 2021
BUY
$88.75 - $119.95 $1.76 Million - $2.38 Million
19,836 Added 30.56%
84,737 $10.1 Million
Q3 2020

Nov 13, 2020
SELL
$75.65 - $93.58 $3.51 Million - $4.34 Million
-46,421 Reduced 41.7%
64,901 $5.66 Million
Q2 2020

Aug 14, 2020
BUY
$84.96 - $118.91 $1.67 Million - $2.33 Million
19,636 Added 21.42%
111,322 $9.97 Million
Q1 2020

May 15, 2020
SELL
$74.34 - $121.82 $693,517 - $1.14 Million
-9,329 Reduced 9.24%
91,686 $9.14 Million
Q4 2019

Feb 14, 2020
SELL
$114.37 - $129.46 $716,756 - $811,325
-6,267 Reduced 5.84%
101,015 $11.6 Million
Q3 2019

Nov 14, 2019
BUY
$117.16 - $138.52 $3.94 Million - $4.65 Million
33,597 Added 45.6%
107,282 $13.5 Million
Q2 2019

Aug 15, 2019
BUY
$81.74 - $120.34 $2.86 Million - $4.2 Million
34,929 Added 90.13%
73,685 $0
Q1 2019

May 14, 2019
BUY
$83.25 - $102.12 $384,781 - $471,998
4,622 Added 13.54%
38,756 $0
Q4 2018

Feb 13, 2019
SELL
$90.66 - $116.63 $447,044 - $575,102
-4,931 Reduced 12.62%
34,134 $3.42 Million
Q3 2018

Nov 14, 2018
BUY
$89.96 - $114.58 $53,076 - $67,602
590 Added 1.53%
39,065 $0
Q2 2018

Aug 14, 2018
SELL
$71.53 - $95.75 $13,948 - $18,671
-195 Reduced 0.5%
38,475 $0
Q1 2018

May 14, 2018
BUY
$60.72 - $74.41 $259,942 - $318,549
4,281 Added 12.45%
38,670 $0
Q4 2017

Feb 09, 2018
BUY
$44.96 - $58.99 $193,328 - $253,657
4,300 Added 14.29%
34,389 $0
Q3 2017

Nov 13, 2017
BUY
$40.38 - $44.87 $1.21 Million - $1.35 Million
30,089
30,089 $0

Others Institutions Holding HAE

# of Institutions
332
Shares Held
53.8M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.87B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email